Pharmaceutical giant Eli Lilly (LLY) lost approximately $120 billion in market value this week following an announcement from competitor Viking Therapeutics ...
I would call Eli Lilly a mega cap and we saw some big drops in mega cap stocks this week $760 billion by the magnificent seven in one day.But Eli Lilly specifically because to your point, Jared is a major mega cap.
$120 billion in value lost on the news that Viking Therapeutics Biotech is getting closer to the finish line with its obesity drug. Maeve Boothby-O’Neill, 27, was suffering with malnutrition but wanted to continue treatment at home rather than remain in hospitalHow might Netanyahu's visit to the US affect cease-fire efforts?
The average cost per litre of regular fuel in cities nationwide climbed 0.6 cents between July 18 and July 25, according to data from Kalibrate.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk, Eli Lilly still top 2 pharma stocks: AnalystNovo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as...
Read more »
FDA approves Eli Lilly's Alzheimer's drug KisunlaEli Lilly's (LLY) Alzheimer's treatment drug Kisunla has gained approval by the US Food and Drug Administration. Yahoo Finance Health Reporter Anjalee...
Read more »
Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billionThe acquisition gives Eli Lilly access to an experimental drug for types of inflammatory bowel diseases
Read more »
Eli Lilly to acquire Morphic in $3.2B dealPharmaceutical giant Eli Lilly (LLY) has reached an agreement to purchase biopharmaceutical company Morphic (MORF) in a deal valued at $3.2 billion. This...
Read more »
Eli Lilly awaits head-to-head study on GLP-1s after new report reaffirms superiorityA new study looked at patient data and concluded Eli Lilly's GLP-1 drugs fare better for weight loss than Novo Nordisk's Ozempic.
Read more »
Novo Nordisk, Eli Lilly fall on data from Roche's weight-loss pillShares of Novo Nordisk (NVO) and Eli Lilly (LLY) are sliding after Roche (ROG.SW, RBO.PA) reported promising early-stage trial data from its weight-loss pill...
Read more »